Skip to main content
Loading

Targeted peptide delivery to specific tissues and cell types, leveraging receptor mediated uptake and tissue selective targeting  approaches

03 Sept 2026
Drug Delivery
  • Overcoming the Endosomal Escape Bottleneck; increasing therapeutic efficacy by dictating intracellular trafficking
  • Blood-Brain Barrier (BBB) Penetration & Transcytosis; challenges in effective use of endogenous receptor systems
  • Exploiting Tumor Microenvironments and Disease-Specific Receptors; Utilization of smart homing peptides
  • Transitioning from Preclinical Models to Clinical Translation; overcoming the discrepancy between pre-clinical models and human physiology
Industry Expert
Peter Abbink PhD., Boston Site Head - Pace Life Sciences 

Pace Life Sciences